SanBio (4592) · FactInterim-period recognition of gain on reversal of stock acquisition rights
Recognition of Gains on Reversal of Stock Acquisition Rights
First written in FY2022-Q3. . Latest entry: FY2027-H1.
6entries
6years
0from disclosures
How it moved
Same theme, other companies
Recognition of Gains on Reversal of Stock Acquisition RightsA theme 15 companies write about · 0 as a headwind · 16 as a tailwind
7 other companies' latest entry also says "Other".
Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 15 companies compared. The sentences above are computed from all 15.Full recordFilings, disclosures and news, newest first
- FY2027-H1Interim-period recognition of gain on reversal of stock acquisition rightsAnnual report
「Gain on reversal of stock acquisition rights — 1,478」
A ¥1 million gain on reversal of stock acquisition rights was recognised as an extraordinary gain in the current interim consolidated accounting period. - FY2025Decrease in gain on reversal of stock acquisition rights recognisedAnnual report
「Gain on reversal of stock acquisition rights 252,328 9,301」
The gain on reversal of stock acquisition rights decreased from ¥252 million in the previous fiscal year to ¥9 million. - FY2025-H1No gain on reversal of stock acquisition rights recognised in the current interim periodAnnual report
「Gain on reversal of stock acquisition rights 71,350 —」
The ¥71 million gain on reversal of stock acquisition rights recognised in the interim period of the previous year was not recognised in the current interim consolidated accounting period. - FY2024Increase in gain on reversal of stock acquisition rights recognisedAnnual report
「Gain on reversal of stock acquisition rights ¥252,328 thousand」
A ¥252 million gain on reversal of stock acquisition rights was recognised as an extraordinary gain. No such gain was recognised in the previous fiscal year, and the amount increased compared with the cumulative quarterly amount through the previous year. - FY2024-Q1Increase in gain on reversal of stock acquisition rights recognisedAnnual report
「Gain on reversal of stock acquisition rights — 71,350」
A ¥71 million gain on reversal of stock acquisition rights was recognised as an extraordinary gain. This was up from ¥29 million in the cumulative previous consolidated fiscal year. - FY2022-Q3First statedAnnual report
「Extraordinary gains Gain on reversal of stock acquisition rights — 29,487」
The gain on reversal of stock acquisition rights was reported for the first time as an extraordinary gain in the cumulative first nine months of the current consolidated fiscal period, at ¥29 million.